Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-06

AUTHORS

Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, Judith-Anne W. Chapman, Lois E. Shepherd, Timothy J. Whelan, Bassam I. Mattar, Jose A. Bufill, William C. Schultz, Irving E. LaFrancis, Gauri G. Nagargoje, Radhakrishna Vemuri, Daniel A. Nikcevich, George W. Sledge, David Cella

ABSTRACT

PURPOSE: Aromatase inhibitors are the most commonly prescribed adjuvant endocrine therapy for hormone-dependent early breast cancer in postmenopausal women. Among Canadian Cancer Trials Group MA.27 participants, anastrozole and exemestane had comparable 5-year event-free survival. This companion study examined differences in patient-reported treatment-related symptoms (TRS) and health-related quality of life (HRQL) among postmenopausal women randomized to anastrozole or exemestane. METHODS: MA.27 participants (N = 686, of 7576) randomized to 5 years of anastrozole (1 mg/day, n = 371, Arm A) or exemestane (25 mg/day, n = 315, Arm E) completed the 56-item Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) questionnaire to assess TRS and HRQL. The FACT-ES was completed at baseline, 3, 6, 12, and 24 months. RESULTS: No significant differences in FACT-ES median scores measuring TRS and HRQL were observed between treatment arms at any time point. Change in TRS from baseline was statistically significant at 3, 6, 12, and 24 months. HRQL was stable over time in both arms. Greater TRS burden was associated with poorer HRQL (coefficient = 0.57, p < 0.001). Twenty percent of patients discontinued AI therapy by month 24 and 32% discontinued AIs at 4 years. In both arms, patients reporting more side effect bother prior to initiating study treatment had a higher risk of discontinuing treatment before completing protocol therapy (hazard ratio [HR] 1.29, 95% CI 1.08-1.55, p = 0.01). CONCLUSIONS: TRS and HRQL were comparable between anastrozole and exemestane. TRS negatively affect HRQL. Women who report being bothered by treatment side effects prior to initiating an AI are at increased risk for early treatment discontinuation. More... »

PAGES

537-548

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-018-4713-2

DOI

http://dx.doi.org/10.1007/s10549-018-4713-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1101079264

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29455298


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anastrozole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androstadienes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Reported Outcome Measures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postmenopause", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, 27151, Winston Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Lynne I.", 
        "id": "sg:person.0753273152.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753273152.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "Fengmin", 
        "id": "sg:person.0732601025.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732601025.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goss", 
        "givenName": "Paul E.", 
        "id": "sg:person.01132017221.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132017221.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian Cancer Trials Group (CCTG), Kingston, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chapman", 
        "givenName": "Judith-Anne W.", 
        "id": "sg:person.014662070262.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014662070262.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Canadian Cancer Trials Group (CCTG), Kingston, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shepherd", 
        "givenName": "Lois E.", 
        "id": "sg:person.01022605023.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022605023.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Canadian Cancer Trials Group (CCTG), Kingston, Canada", 
            "McMaster University, Hamilton, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whelan", 
        "givenName": "Timothy J.", 
        "id": "sg:person.0673313261.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673313261.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wichita NCORP, Wichita, KA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mattar", 
        "givenName": "Bassam I.", 
        "id": "sg:person.01254541743.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254541743.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Michiana Hematology-Oncology, P.C., Mishawaka, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bufill", 
        "givenName": "Jose A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Swedish American Regional Cancer Center, Rockford, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schultz", 
        "givenName": "William C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mercy Hospital", 
          "id": "https://www.grid.ac/institutes/grid.429362.8", 
          "name": [
            "Mercy Hospital-Joplin, Joplin, MO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LaFrancis", 
        "givenName": "Irving E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pittsburgh Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412689.0", 
          "name": [
            "Mercy Hospital, Coon Rapids, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagargoje", 
        "givenName": "Gauri G.", 
        "id": "sg:person.01156254243.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156254243.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "West Michigan Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.430904.a", 
          "name": [
            "West Michigan Cancer Center, Kalamazoo, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vemuri", 
        "givenName": "Radhakrishna", 
        "id": "sg:person.01333142412.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333142412.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Essentia Health", 
          "id": "https://www.grid.ac/institutes/grid.428919.f", 
          "name": [
            "Essentia Health Cancer Center, Duluth, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nikcevich", 
        "givenName": "Daniel A.", 
        "id": "sg:person.01140313343.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140313343.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stanford University", 
          "id": "https://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Stanford University, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sledge", 
        "givenName": "George W.", 
        "id": "sg:person.01215152726.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215152726.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern University", 
          "id": "https://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Northwestern University, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cella", 
        "givenName": "David", 
        "id": "sg:person.012000260477.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012000260477.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2009.23.1274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000519560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70182-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002955805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmp0911494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008064319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(08)70259-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014208100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.06.078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015676595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.57.6926", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018226934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2012.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018437334", 
          "https://doi.org/10.1038/bjc.2012.43"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.8617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018605357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.4780111408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020959785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-007-9548-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028962259", 
          "https://doi.org/10.1007/s10549-007-9548-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-007-9548-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028962259", 
          "https://doi.org/10.1007/s10549-007-9548-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006263818115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032185952", 
          "https://doi.org/10.1023/a:1006263818115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.03.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037475195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.44.7805", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038559296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.08.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041745060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044502122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.42.5967", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046687281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.20004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049645754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1524-4733.2007.00275.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049954810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.18.3295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074698117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1983.1.11.710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1081892555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.31133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092654335"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/3001968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1102728208"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06", 
    "datePublishedReg": "2018-06-01", 
    "description": "PURPOSE: Aromatase inhibitors are the most commonly prescribed adjuvant endocrine therapy for hormone-dependent early breast cancer in postmenopausal women. Among Canadian Cancer Trials Group MA.27 participants, anastrozole and exemestane had comparable 5-year event-free survival. This companion study examined differences in patient-reported treatment-related symptoms (TRS) and health-related quality of life (HRQL) among postmenopausal women randomized to anastrozole or exemestane.\nMETHODS: MA.27 participants (N\u00a0=\u00a0686, of 7576) randomized to 5 years of anastrozole (1\u00a0mg/day, n\u00a0=\u00a0371, Arm A) or exemestane (25\u00a0mg/day, n\u00a0=\u00a0315, Arm E) completed the 56-item Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) questionnaire to assess TRS and HRQL. The FACT-ES was completed at baseline, 3, 6, 12, and 24\u00a0months.\nRESULTS: No significant differences in FACT-ES median scores measuring TRS and HRQL were observed between treatment arms at any time point. Change in TRS from baseline was statistically significant at 3, 6, 12, and 24\u00a0months. HRQL was stable over time in both arms. Greater TRS burden was associated with poorer HRQL (coefficient\u00a0=\u00a00.57, p\u00a0<\u00a00.001). Twenty percent of patients discontinued AI therapy by month 24 and 32% discontinued AIs at 4\u00a0years. In both arms, patients reporting more side effect bother prior to initiating study treatment had a higher risk of discontinuing treatment before completing protocol therapy (hazard ratio [HR] 1.29, 95% CI 1.08-1.55, p\u00a0=\u00a00.01).\nCONCLUSIONS: TRS and HRQL were comparable between anastrozole and exemestane. TRS negatively affect HRQL. Women who report being bothered by treatment side effects prior to initiating an AI are at increased risk for early treatment discontinuation.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10549-018-4713-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3802225", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3537128", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3803832", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3801839", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693677", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3537027", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3624175", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3801650", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3624256", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3803904", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3535678", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3801767", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3803210", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "169"
      }
    ], 
    "name": "Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)", 
    "pagination": "537-548", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0df1c078c6d1bdbbd79d2c46e571dc7f4fe7b6247350e8d7eeb611c8e2672e6d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29455298"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8111104"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10549-018-4713-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1101079264"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10549-018-4713-2", 
      "https://app.dimensions.ai/details/publication/pub.1101079264"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60354_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10549-018-4713-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-018-4713-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-018-4713-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-018-4713-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-018-4713-2'


 

This table displays all metadata directly associated to this object as RDF triples.

370 TRIPLES      21 PREDICATES      70 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-018-4713-2 schema:about N06ccbacd0b9141538c374f0ed3a55b5c
2 N1f516b894fc547329eba8c96582ba8c2
3 N446b47d89fb141cfa7acd5743b3aa5a9
4 N4caf68e89be949ad8b85ca6016ef5d2b
5 N4ea93151778141b59044e62aded241ab
6 N58e97bc99baf411fbeafb30deddbecc5
7 N641babcae64841fa893d590518f2db2d
8 N7ce759038d9a4ee68a90ed3698561ff2
9 N9cc8d50e3eff4741ab040401aa872b2a
10 Na591b62da04a4ab393f0d1d989097361
11 Nabfc7fd8a99348749c15377c3aee70b2
12 Nbc258e258dab4fe9a0dd27d5667f82b2
13 Nd387d818320044009cc025c7e7112692
14 Nd4858ce94d9e4b76a135c372dfa68881
15 Nd5cd3b832e044199b6ccfa85ba16160a
16 Nd83f1ac4fc484f8e939da28bedff5d37
17 Nda03d39766ce4f68a8519ab0d1e86504
18 Nfc63c45157a3407ea20516a5ed965d1d
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N6ac0dfbf9ea64990a32da5fc5ca3e87e
22 schema:citation sg:pub.10.1007/s10549-007-9548-1
23 sg:pub.10.1023/a:1006263818115
24 sg:pub.10.1038/bjc.2012.43
25 https://doi.org/10.1002/cncr.11745
26 https://doi.org/10.1002/cncr.31133
27 https://doi.org/10.1002/sim.4780111408
28 https://doi.org/10.1016/s1470-2045(08)70182-7
29 https://doi.org/10.1016/s1470-2045(08)70259-6
30 https://doi.org/10.1056/nejmp0911494
31 https://doi.org/10.1080/01621459.1958.10501452
32 https://doi.org/10.1111/j.1524-4733.2007.00275.x
33 https://doi.org/10.1200/jco.1983.1.11.710
34 https://doi.org/10.1200/jco.2000.18.18.3295
35 https://doi.org/10.1200/jco.2004.03.025
36 https://doi.org/10.1200/jco.2004.06.078
37 https://doi.org/10.1200/jco.2004.08.029
38 https://doi.org/10.1200/jco.2006.08.8617
39 https://doi.org/10.1200/jco.2009.23.1274
40 https://doi.org/10.1200/jco.2012.42.5967
41 https://doi.org/10.1200/jco.2012.44.7805
42 https://doi.org/10.1200/jco.2014.57.6926
43 https://doi.org/10.2307/3001968
44 https://doi.org/10.3322/caac.20004
45 schema:datePublished 2018-06
46 schema:datePublishedReg 2018-06-01
47 schema:description PURPOSE: Aromatase inhibitors are the most commonly prescribed adjuvant endocrine therapy for hormone-dependent early breast cancer in postmenopausal women. Among Canadian Cancer Trials Group MA.27 participants, anastrozole and exemestane had comparable 5-year event-free survival. This companion study examined differences in patient-reported treatment-related symptoms (TRS) and health-related quality of life (HRQL) among postmenopausal women randomized to anastrozole or exemestane. METHODS: MA.27 participants (N = 686, of 7576) randomized to 5 years of anastrozole (1 mg/day, n = 371, Arm A) or exemestane (25 mg/day, n = 315, Arm E) completed the 56-item Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) questionnaire to assess TRS and HRQL. The FACT-ES was completed at baseline, 3, 6, 12, and 24 months. RESULTS: No significant differences in FACT-ES median scores measuring TRS and HRQL were observed between treatment arms at any time point. Change in TRS from baseline was statistically significant at 3, 6, 12, and 24 months. HRQL was stable over time in both arms. Greater TRS burden was associated with poorer HRQL (coefficient = 0.57, p < 0.001). Twenty percent of patients discontinued AI therapy by month 24 and 32% discontinued AIs at 4 years. In both arms, patients reporting more side effect bother prior to initiating study treatment had a higher risk of discontinuing treatment before completing protocol therapy (hazard ratio [HR] 1.29, 95% CI 1.08-1.55, p = 0.01). CONCLUSIONS: TRS and HRQL were comparable between anastrozole and exemestane. TRS negatively affect HRQL. Women who report being bothered by treatment side effects prior to initiating an AI are at increased risk for early treatment discontinuation.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf Nea72ae68e8f5413d8ec4443815598a9c
52 Nfb6a75572ed649558dfc13dadf6fbd75
53 sg:journal.1092777
54 schema:name Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
55 schema:pagination 537-548
56 schema:productId N05e2d400fc0a43128702da178ebcd0e1
57 N0f3ddc5f3ec54d6792dcf7951b16f6ac
58 N35055cbcfe1c4f20a6b1243147a14c56
59 Nd824d03ce33c4e9492d57cf7e65266c4
60 Nffca9d2be6714b81b6418ea5cfed9019
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101079264
62 https://doi.org/10.1007/s10549-018-4713-2
63 schema:sdDatePublished 2019-04-11T11:03
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N08b7d3d29fb24d6399f4a114489aa034
66 schema:url https://link.springer.com/10.1007%2Fs10549-018-4713-2
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N05e2d400fc0a43128702da178ebcd0e1 schema:name dimensions_id
71 schema:value pub.1101079264
72 rdf:type schema:PropertyValue
73 N06ccbacd0b9141538c374f0ed3a55b5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Breast Neoplasms
75 rdf:type schema:DefinedTerm
76 N08b7d3d29fb24d6399f4a114489aa034 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N0f3ddc5f3ec54d6792dcf7951b16f6ac schema:name pubmed_id
79 schema:value 29455298
80 rdf:type schema:PropertyValue
81 N1cb23b31f9ec4107be03499f6d987132 schema:name Michiana Hematology-Oncology, P.C., Mishawaka, IN, USA
82 rdf:type schema:Organization
83 N1f516b894fc547329eba8c96582ba8c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Randomized Controlled Trials as Topic
85 rdf:type schema:DefinedTerm
86 N24c4153cf2ba4b0ea3474efdb01e9677 rdf:first sg:person.012000260477.10
87 rdf:rest rdf:nil
88 N2be67894f37b490ca4bdf873fa63327e schema:affiliation N94cff34ca14f4d6da1dbb622fd7ab369
89 schema:familyName Schultz
90 schema:givenName William C.
91 rdf:type schema:Person
92 N2e8551778d9843dabdd107b5ea71a885 rdf:first N41027131644a4d569980ce4e9ddc0232
93 rdf:rest N40ae1efd6be54f21846f233804943c91
94 N35055cbcfe1c4f20a6b1243147a14c56 schema:name doi
95 schema:value 10.1007/s10549-018-4713-2
96 rdf:type schema:PropertyValue
97 N387506e32b3c4551b8d278bc9d1304ad rdf:first sg:person.0673313261.29
98 rdf:rest Ne5cf91e6d7dc488f870d553af2b67b70
99 N40ae1efd6be54f21846f233804943c91 rdf:first N2be67894f37b490ca4bdf873fa63327e
100 rdf:rest N4b20e8197f2b4275a72b496b5a7d034f
101 N41027131644a4d569980ce4e9ddc0232 schema:affiliation N1cb23b31f9ec4107be03499f6d987132
102 schema:familyName Bufill
103 schema:givenName Jose A.
104 rdf:type schema:Person
105 N446b47d89fb141cfa7acd5743b3aa5a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Androstadienes
107 rdf:type schema:DefinedTerm
108 N4b20e8197f2b4275a72b496b5a7d034f rdf:first Ncbb36defcc7e40b692db0edbaeceae74
109 rdf:rest Nf54ada678dfe4cfaa7f09611ef2d9c21
110 N4caf68e89be949ad8b85ca6016ef5d2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Humans
112 rdf:type schema:DefinedTerm
113 N4ea93151778141b59044e62aded241ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 N5676edd2c67b48b69848c07f7e9842d2 rdf:first sg:person.01022605023.27
117 rdf:rest N387506e32b3c4551b8d278bc9d1304ad
118 N58e97bc99baf411fbeafb30deddbecc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Medication Adherence
120 rdf:type schema:DefinedTerm
121 N607266be50474c1eb3038b04d6c2228f rdf:first sg:person.01215152726.96
122 rdf:rest N24c4153cf2ba4b0ea3474efdb01e9677
123 N641babcae64841fa893d590518f2db2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Aged
125 rdf:type schema:DefinedTerm
126 N6ac0dfbf9ea64990a32da5fc5ca3e87e rdf:first sg:person.0753273152.69
127 rdf:rest Nd2b934dad38343eebf92b81a830907ba
128 N79ba03caa1204b0bbf04a354169006b7 rdf:first sg:person.01132017221.32
129 rdf:rest N8a9159ae5e424c75979414cfd2183304
130 N7ce759038d9a4ee68a90ed3698561ff2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Kaplan-Meier Estimate
132 rdf:type schema:DefinedTerm
133 N8a9159ae5e424c75979414cfd2183304 rdf:first sg:person.014662070262.76
134 rdf:rest N5676edd2c67b48b69848c07f7e9842d2
135 N94cff34ca14f4d6da1dbb622fd7ab369 schema:name Swedish American Regional Cancer Center, Rockford, IL, USA
136 rdf:type schema:Organization
137 N9cc8d50e3eff4741ab040401aa872b2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Neoplasm Staging
139 rdf:type schema:DefinedTerm
140 Na591b62da04a4ab393f0d1d989097361 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Patient Reported Outcome Measures
142 rdf:type schema:DefinedTerm
143 Nabfc7fd8a99348749c15377c3aee70b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Quality of Life
145 rdf:type schema:DefinedTerm
146 Nac27942dcd224a439b0e1e2ae30828c2 rdf:first sg:person.01140313343.75
147 rdf:rest N607266be50474c1eb3038b04d6c2228f
148 Nafb8ce73c4764f909308c2581b186ef2 rdf:first sg:person.01333142412.66
149 rdf:rest Nac27942dcd224a439b0e1e2ae30828c2
150 Nb01dfddb44164d6ca4f97b8f905d8644 schema:name Wichita NCORP, Wichita, KA, USA
151 rdf:type schema:Organization
152 Nbc258e258dab4fe9a0dd27d5667f82b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Middle Aged
154 rdf:type schema:DefinedTerm
155 Ncbb36defcc7e40b692db0edbaeceae74 schema:affiliation https://www.grid.ac/institutes/grid.429362.8
156 schema:familyName LaFrancis
157 schema:givenName Irving E.
158 rdf:type schema:Person
159 Nd2b934dad38343eebf92b81a830907ba rdf:first sg:person.0732601025.54
160 rdf:rest N79ba03caa1204b0bbf04a354169006b7
161 Nd387d818320044009cc025c7e7112692 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Aged, 80 and over
163 rdf:type schema:DefinedTerm
164 Nd4858ce94d9e4b76a135c372dfa68881 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Postmenopause
166 rdf:type schema:DefinedTerm
167 Nd5cd3b832e044199b6ccfa85ba16160a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Adult
169 rdf:type schema:DefinedTerm
170 Nd824d03ce33c4e9492d57cf7e65266c4 schema:name readcube_id
171 schema:value 0df1c078c6d1bdbbd79d2c46e571dc7f4fe7b6247350e8d7eeb611c8e2672e6d
172 rdf:type schema:PropertyValue
173 Nd83f1ac4fc484f8e939da28bedff5d37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Neoplasm Metastasis
175 rdf:type schema:DefinedTerm
176 Nda03d39766ce4f68a8519ab0d1e86504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Combined Modality Therapy
178 rdf:type schema:DefinedTerm
179 Ndcf0a3ec1e784afdba75638f33a639f8 schema:name Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Medical Center Boulevard, 27151, Winston Salem, NC, USA
180 rdf:type schema:Organization
181 Ndf2c78096cfa4c8489e9a54da6e046da schema:name Canadian Cancer Trials Group (CCTG), Kingston, Canada
182 rdf:type schema:Organization
183 Ne5cf91e6d7dc488f870d553af2b67b70 rdf:first sg:person.01254541743.06
184 rdf:rest N2e8551778d9843dabdd107b5ea71a885
185 Ne8c77fa9469d46d0a938669946f3f402 schema:name Canadian Cancer Trials Group (CCTG), Kingston, Canada
186 rdf:type schema:Organization
187 Nea72ae68e8f5413d8ec4443815598a9c schema:volumeNumber 169
188 rdf:type schema:PublicationVolume
189 Nf32e65a4e2664a93a4a95ee88cb91a1a schema:name Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
190 rdf:type schema:Organization
191 Nf54ada678dfe4cfaa7f09611ef2d9c21 rdf:first sg:person.01156254243.91
192 rdf:rest Nafb8ce73c4764f909308c2581b186ef2
193 Nfb6a75572ed649558dfc13dadf6fbd75 schema:issueNumber 3
194 rdf:type schema:PublicationIssue
195 Nfc63c45157a3407ea20516a5ed965d1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Anastrozole
197 rdf:type schema:DefinedTerm
198 Nffca9d2be6714b81b6418ea5cfed9019 schema:name nlm_unique_id
199 schema:value 8111104
200 rdf:type schema:PropertyValue
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
205 schema:name Clinical Sciences
206 rdf:type schema:DefinedTerm
207 sg:grant.2693677 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
208 rdf:type schema:MonetaryGrant
209 sg:grant.3535678 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
210 rdf:type schema:MonetaryGrant
211 sg:grant.3537027 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
212 rdf:type schema:MonetaryGrant
213 sg:grant.3537128 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
214 rdf:type schema:MonetaryGrant
215 sg:grant.3624175 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
216 rdf:type schema:MonetaryGrant
217 sg:grant.3624256 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
218 rdf:type schema:MonetaryGrant
219 sg:grant.3801650 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
220 rdf:type schema:MonetaryGrant
221 sg:grant.3801767 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
222 rdf:type schema:MonetaryGrant
223 sg:grant.3801839 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
224 rdf:type schema:MonetaryGrant
225 sg:grant.3802225 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
226 rdf:type schema:MonetaryGrant
227 sg:grant.3803210 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
228 rdf:type schema:MonetaryGrant
229 sg:grant.3803832 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
230 rdf:type schema:MonetaryGrant
231 sg:grant.3803904 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-018-4713-2
232 rdf:type schema:MonetaryGrant
233 sg:journal.1092777 schema:issn 0167-6806
234 1573-7217
235 schema:name Breast Cancer Research and Treatment
236 rdf:type schema:Periodical
237 sg:person.01022605023.27 schema:affiliation Ne8c77fa9469d46d0a938669946f3f402
238 schema:familyName Shepherd
239 schema:givenName Lois E.
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022605023.27
241 rdf:type schema:Person
242 sg:person.01132017221.32 schema:affiliation Nf32e65a4e2664a93a4a95ee88cb91a1a
243 schema:familyName Goss
244 schema:givenName Paul E.
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132017221.32
246 rdf:type schema:Person
247 sg:person.01140313343.75 schema:affiliation https://www.grid.ac/institutes/grid.428919.f
248 schema:familyName Nikcevich
249 schema:givenName Daniel A.
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140313343.75
251 rdf:type schema:Person
252 sg:person.01156254243.91 schema:affiliation https://www.grid.ac/institutes/grid.412689.0
253 schema:familyName Nagargoje
254 schema:givenName Gauri G.
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156254243.91
256 rdf:type schema:Person
257 sg:person.012000260477.10 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
258 schema:familyName Cella
259 schema:givenName David
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012000260477.10
261 rdf:type schema:Person
262 sg:person.01215152726.96 schema:affiliation https://www.grid.ac/institutes/grid.168010.e
263 schema:familyName Sledge
264 schema:givenName George W.
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215152726.96
266 rdf:type schema:Person
267 sg:person.01254541743.06 schema:affiliation Nb01dfddb44164d6ca4f97b8f905d8644
268 schema:familyName Mattar
269 schema:givenName Bassam I.
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254541743.06
271 rdf:type schema:Person
272 sg:person.01333142412.66 schema:affiliation https://www.grid.ac/institutes/grid.430904.a
273 schema:familyName Vemuri
274 schema:givenName Radhakrishna
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333142412.66
276 rdf:type schema:Person
277 sg:person.014662070262.76 schema:affiliation Ndf2c78096cfa4c8489e9a54da6e046da
278 schema:familyName Chapman
279 schema:givenName Judith-Anne W.
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014662070262.76
281 rdf:type schema:Person
282 sg:person.0673313261.29 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
283 schema:familyName Whelan
284 schema:givenName Timothy J.
285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673313261.29
286 rdf:type schema:Person
287 sg:person.0732601025.54 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
288 schema:familyName Zhao
289 schema:givenName Fengmin
290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732601025.54
291 rdf:type schema:Person
292 sg:person.0753273152.69 schema:affiliation Ndcf0a3ec1e784afdba75638f33a639f8
293 schema:familyName Wagner
294 schema:givenName Lynne I.
295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753273152.69
296 rdf:type schema:Person
297 sg:pub.10.1007/s10549-007-9548-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028962259
298 https://doi.org/10.1007/s10549-007-9548-1
299 rdf:type schema:CreativeWork
300 sg:pub.10.1023/a:1006263818115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032185952
301 https://doi.org/10.1023/a:1006263818115
302 rdf:type schema:CreativeWork
303 sg:pub.10.1038/bjc.2012.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018437334
304 https://doi.org/10.1038/bjc.2012.43
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1002/cncr.11745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044502122
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1002/cncr.31133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092654335
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1002/sim.4780111408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020959785
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/s1470-2045(08)70182-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002955805
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/s1470-2045(08)70259-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014208100
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1056/nejmp0911494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008064319
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1111/j.1524-4733.2007.00275.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049954810
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1200/jco.1983.1.11.710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1081892555
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1200/jco.2000.18.18.3295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074698117
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1200/jco.2004.03.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037475195
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1200/jco.2004.06.078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015676595
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1200/jco.2004.08.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041745060
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1200/jco.2006.08.8617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018605357
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1200/jco.2009.23.1274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000519560
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1200/jco.2012.42.5967 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046687281
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1200/jco.2012.44.7805 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038559296
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1200/jco.2014.57.6926 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018226934
341 rdf:type schema:CreativeWork
342 https://doi.org/10.2307/3001968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1102728208
343 rdf:type schema:CreativeWork
344 https://doi.org/10.3322/caac.20004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049645754
345 rdf:type schema:CreativeWork
346 https://www.grid.ac/institutes/grid.16753.36 schema:alternateName Northwestern University
347 schema:name Northwestern University, Chicago, IL, USA
348 rdf:type schema:Organization
349 https://www.grid.ac/institutes/grid.168010.e schema:alternateName Stanford University
350 schema:name Stanford University, Stanford, CA, USA
351 rdf:type schema:Organization
352 https://www.grid.ac/institutes/grid.25073.33 schema:alternateName McMaster University
353 schema:name Canadian Cancer Trials Group (CCTG), Kingston, Canada
354 McMaster University, Hamilton, ON, Canada
355 rdf:type schema:Organization
356 https://www.grid.ac/institutes/grid.412689.0 schema:alternateName University of Pittsburgh Medical Center
357 schema:name Mercy Hospital, Coon Rapids, MN, USA
358 rdf:type schema:Organization
359 https://www.grid.ac/institutes/grid.428919.f schema:alternateName Essentia Health
360 schema:name Essentia Health Cancer Center, Duluth, MN, USA
361 rdf:type schema:Organization
362 https://www.grid.ac/institutes/grid.429362.8 schema:alternateName Mercy Hospital
363 schema:name Mercy Hospital-Joplin, Joplin, MO, USA
364 rdf:type schema:Organization
365 https://www.grid.ac/institutes/grid.430904.a schema:alternateName West Michigan Cancer Center
366 schema:name West Michigan Cancer Center, Kalamazoo, MI, USA
367 rdf:type schema:Organization
368 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
369 schema:name Dana Farber Cancer Institute, Boston, MA, USA
370 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...